location icon

pageTitle

Disclaimers: PoNS™ is an authorized medical device and commercially available in Canada. PoNS™ is not commercially available in the US, EU, or Australia.

The device is intended for use as a short term treatment (14 weeks) of chronic balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with physical therapy. The device is intended for use as a short term treatment (14 weeks) of gait deficit due to mild and moderate symptoms from MS and is to be used in conjunction with physical therapy.

Jayne was the first MS patient to receive PoNS Treatment™ in British Columbia; however, she was not the first Canada-wide.